Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Revenue

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹163 Cr₹179 Cr₹141 Cr₹115 Cr₹11,271,608 Cr

What is the latest Revenue of MEDICAMEN BIOTECH ?

The latest Revenue ratio of MEDICAMEN BIOTECH is ₹163 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹163 Cr
Mar2025₹179 Cr
Mar2024₹141 Cr
Mar2023₹115 Cr
Mar2022₹11,271,608 Cr

How is Revenue of MEDICAMEN BIOTECH Trending?

Years Revenue % Change
Mar2026 ₹163 Cr
-9.35
Mar2025 ₹179 Cr
27.29
Mar2024 ₹141 Cr
22.02
Mar2023 ₹115 Cr
-100.00
Mar2022 ₹11,271,608 Cr -

Compare Revenue of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹360.3 Cr -3.9% -21.1% -24.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-3.9%

-21.1%

-24.9%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses